2018

Lipidor: First Patient In for Phase III trials of new high- comfort, high-control anti-psoriasis spray

CERBIOS AND IRB COLLABORATE ON DEVELOPING ANTIBODIES TARGETED AT LEUKEMIA CELLS
La bilancia commerciale ticinese – L’export cantonale nel 2017
PKU GOLIKE debuts at SSIEM 2018 Conference: science driven innovation behind the medical food for PKU management of APR Applied Pharma Research

Farma Industria Ticino and Credit Suisse Award for best student

38a Assemblea generale ordinaria di FIT
Swissmedic – informativa speciale OATer IV
Linnea obtained the Certificate of Suitability (CEP) for hyoscine butylbromide released by EDQM

Linkedin